Reigan, Philip
- University of Colorado · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #33,290
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$340.4K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#33,290
By linked amount among FY2023 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Reigan, Philip as a PI. Multi-PI records show the full award amount for context.
- 5R01CA251534-03R01Contact PIDevelopment of AMPK Inhibitors for the treatment of leukemiaUniversity of Colorado · Pharmacology (NIH department code)$340.4Kaward amount
Award organization
Organizations that administered FY2023 awards listing Reigan, Philip as a PI.
FY2023 award administered by University of Colorado (CO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardUniversity of Colorado
- 2014R01 Grant Holder
- 2021$500K Cumulative Funding
- 2022$1M Cumulative Funding